Current Report Filing (8-k)

 

---

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

---

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

---

 

Date of Report (Date of earliest event reported):  May 1, 2017

 

AmerisourceBergen Corporation

(Exact name of Registrant as specified in its charter)

 

Delaware		1-16671		23-3079390
(State or Other Jurisdiction of Incorporation or Organization)		Commission File Number		(I.R.S. Employer Identification Number)

 

---

 

1300 Morris Drive Chesterbrook, PA		19087
(Address of principal executive offices)		(Zip Code)

 

Registrant’s telephone number, including area code:   [phone]

 

N/A

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):

 

o             Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o             Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o             Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o             Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

---

 

---

---

 

Item 7.01.                                         Regulation FD Disclosure.

 

On May 1, 2017, AmerisourceBergen Corporation (the “Company”) issued a news release announcing that the Company has signed a new five-year agreement to supply pharmaceuticals to Express Scripts Holding Company. A copy of the news release is attached to this Current Report as Exhibit 99.1.

The information contained in this Current Report, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

 

Item 9.01.                                         Financial Statements and Exhibits.

 

(d)                                  Exhibits.

 

99.1                         News Release, dated May 1, 2017, of AmerisourceBergen Corporation.

 

2

---

---

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

	AMERISOURCEBERGEN CORPORATION
Date: May 1, 2017	By:	/s/ Tim G. Guttman
	Name:	Tim G. Guttman
	Title:	Executive Vice President & Chief Financial Officer

 

3

---

 

 

---

EXHIBIT INDEX

Exhibit Number		Description of Exhibit
99.1		News Release, dated May 1, 2017 of AmerisourceBergen Corporation.